View all newsletters
Thermo Fisher Scientific agreed to acquire Dutch contract development and manufacturing organisation (CDMO) Patheon for $7.2bn. AstraZeneca entered an agreement to provide the commercial rights for…
By
AbbVie acquired biopharmaceutical firm Pharmacyclics for $21bn, GSK and UNC-Chapel Hill announced the creation of its HIV Cure Centre,…
By
Mylan buys Perrigo and Teva made bid to acquire Mylan, Takeda to pay $2.4bn to settle Actos drug claims…
By
Salix accepted Valeant's $15.8bn offer, AstraZeneca and HSCI partnered to develop new medicines for diabetes; while India introduced new…
By
UK MPs voted in favour of three-person IVF technique; Merck and MPP partnered to supply paediatric HIV drug in…
By
Pfizer agreed for a $400m settlement with investors, Eli Lilly bought Novartis Animal Health, and MSG pleads for a…
By
Ireland-based pharmaceutical company Actavis signed an agreement to acquire US-based Botox-maker Allergan for $66bn or $219 per share.
ByNew Zealand's competition watchdog Commerce Commission has approved Mylan's purchase of Abbott Laboratories's generic medicines arm Established Pharmaceuticals.
ByGermany has banned 80 generic drugs whose clinical trials undertaken by GVK Biosciences in India were found to be…
ByThank you for subscribing to Pharmaceutical Technology